Plan B

1 stories · following the connections

Business

Agile Therapeutics Announces a Poster Presentation of its SECURE Phase 3 Study at the Contraceptive Technology 2017 Conference

By Nasdaq OMXMar 16, 2017, 8:30 PM UTC